How dermatologists, aesthetic doctors and clinics put their own name on a skincare range in Malaysia: the formula routes, starting quantities, what the label may claim, who holds the NPRA notification, and where the products are sold.
Disclosure: This article is published by ORIZI Group and may refer to our own manufacturing experience, services and capabilities. External factual claims are supported by cited sources.
Key takeaways
- A clinic brand is a cosmetic, not a separate legal class: in Malaysia it is notified to NPRA like any other cosmetic, and its name and claims must not be medicinal.
- The notification holder must be a Malaysian-incorporated company with a health or cosmetic business scope; it may or may not be the product owner.
- Clinics can start small: selected professional or ready-product options can begin from 12 units, and eligible cosmetic formats can pilot from 50 units under Ready2Brand before moving to adapted or custom formulas as demand proves out.
- Prescription-only actives belong to the registered-medicine route; substances on the Poisons List are not allowed in cosmetics unless exempted.
- Some post-procedure products, such as scar and wound products, can be medical devices rather than cosmetics — classify before you formulate.
What is a doctor’s own-brand skincare line?
A doctor’s own-brand skincare line is a range of cosmetics developed for a dermatologist, aesthetic doctor or clinic, manufactured by a contract manufacturer and sold under the practice’s brand. It sits between home care and the treatment room: cleansers, serums, moisturisers, sunscreens and recovery products that patients use between visits. “Cosmeceutical” is a marketing term, not a legal category in Malaysia — NPRA’s cosmetic guidelines regulate these products as cosmetics. Interest is real but specialised: “cosmeceutical” drew 100–1,000 average monthly searches in Malaysia and “medical grade skincare” 10–100 (Google Keyword Planner ranges, Malaysia, September 2025–August 2026).
How does a clinic own-brand line work, step by step?
- Brief. Define the patient concern, the role of each product in the clinic routine, the target price and the channels.
- Classification and claims screen. Decide whether each product is a cosmetic, a medical device or a registered medicine before any formula work starts.
- Route. Choose a ready product, an adapted ready formula, a custom formula or contract filling of the clinic’s own formula.
- Samples. Review texture, fragrance (or none), packaging and dosing with the doctors who will recommend it.
- Testing. Stability, packaging compatibility, microbiology and any safety or performance work the claims need — see product testing.
- NPRA notification. The notification holder files each product and variant in NPRA’s QUEST system and receives a notification note before manufacture.
- Production and launch. Manufacture, label and train clinic staff on approved usage wording.
- Review and reorder. Track patient repeat purchases and plan the next product in the routine.
Which formula route fits a clinic: ready, adapted or custom?
| Route | What it is | Starting point | Fits a clinic that wants |
|---|---|---|---|
| Ready2Brand (private label) | Ready cosmetic products with the clinic’s brand | From 12 units for selected professional or ready-product options; Ready2Brand pilot from 50 units, about RM3,000, 1–2 weeks for eligible cosmetic and personal-care formats | To test one or two SKUs with patients before committing |
| Ready Formulas (ODM) | A library formula adapted for texture, fragrance-free options or packaging | Quoted per project | A distinctive range without a full development cycle |
| OEM2YOU (custom OEM) | A formula developed to the doctor’s brief and active strategy | Quoted per format and packaging | A signature product built around specific actives |
| Contract filling | The clinic supplies its own formula; the factory fills and packs | Quoted per format | To scale a formula the practice already owns |
For ideas by concern, our dermatology and aesthetic skincare portfolio sets out 44 professional concepts in 12 collections, from barrier care to pigmentation and post-procedure recovery.
What can a doctor’s skincare line claim?
NPRA’s rule is short: claimed benefits must be justified by substantial evidence or by the formulation itself, and a cosmetic should not use a name or claims that are medicinal in nature or beyond cosmetic scope. A doctor’s name on the pack raises expectations, so the wording has to be more disciplined, not less. The examples below are illustrative directions; final wording is checked against NPRA’s claims and advertising guidance for each product.
| Concern | Cosmetic direction | Moves outside cosmetic scope |
|---|---|---|
| After a procedure | Soothes and comforts the skin; supports the skin barrier | Heals wounds; prevents infection |
| Pigmentation | Brightens; reduces the look of dark spots | Treats melasma |
| Blemish-prone skin | Helps control excess oil; cleanses pores | Cures acne |
| Sensitive skin | Formulated for sensitive skin; fragrance-free | Treats eczema or dermatitis |
Ingredients follow the same logic. NPRA prohibits cosmetics containing substances on the Poisons List (unless exempted) or in its Annex II, and limits Annex III substances to their stated conditions. Prescription-strength actives therefore belong to the registered-medicine route, not to a cosmetic OEM brief. For how claims shape a formula, see a skin longevity brief is a claims decision before it is a formula.
Who holds the NPRA notification, and what does it involve?
The cosmetic notification holder (CNH) is the Malaysian company responsible for placing the product on the market. NPRA requires it to be a locally incorporated company or legal entity registered with the Companies Commission of Malaysia, with a health or cosmetic business scope in its constitution; the CNH may or may not be the product owner. A clinic that holds the notifications in its own company keeps direct control of them; appointing another Malaysian company as CNH is the alternative.
- Fee: RM50 per product and per variant, with the same fee for renewal.
- Validity: two years; renew no later than one month before expiry.
- Timing: the product may be manufactured or imported once the notification note is issued.
- Ongoing duties: keep a product information file available, recall products if directed, report serious adverse events, and use a manufacturer that complies with cosmetic GMP.
Our guide to NPRA GMP vs ISO 22716 explains the manufacturing side, and our regulatory affairs team can prepare the notification file with the clinic.
Where do clinic brands sell: clinic shelf, pharmacy or online?
| Channel | What it asks of the product |
|---|---|
| Clinic dispensing | A routine that matches treatments; clear home-use instructions; consistent claims between staff and pack |
| Pharmacy chains | Retail-ready packaging, supplier documentation and steady supply — see what beauty brands prepare before entering pharmacy chains |
| Online and social commerce | Advertising that follows NPRA’s cosmetic advertising guideline; the same claims online as on the label |
| Post-procedure kits | Fragrance-free, barrier-focused products sold as a system — see post-procedure skin recovery |
ORIZI perspective: where clinic projects need the most care
Clinic brands are one of several segments ORIZI Group manufactures for, alongside retail, online and export brands. Skincare is made by Dr Orizi (M) Sdn. Bhd., which holds NPRA cosmetic GMP (since 2024), ISO 22716 (since 2022) and JAKIM Halal (since 2015). Where a clinic range crosses into medical devices, such as scar gels or barrier products with device claims, the work moves to the group’s medical-device manufacturers, Imedify Medical Solution Sdn. Bhd. (ISO 13485 since 2024) and Skyler Medical Manufacturing Sdn. Bhd. (ISO 13485 since 2022), which hold MDA establishment licences. Our post on cosmetic or medical device classification shows where those lines fall.
Our team attended the 51st PDM Annual Dermatology Conference in September 2026, where skin-barrier repair, atopic dermatitis and itch relief dominated the talks and exhibition floor we saw (our conference notes). One principle we apply to every clinic brief: a higher percentage of an active is not automatically better — stability, pH, delivery and tolerance decide whether a product performs on real skin.
Risks, limitations and common mistakes
- Medical wording on a cosmetic. “Treats”, “heals” or disease names on the pack or in clinic posts can take a product outside cosmetic scope.
- Clinical-looking packaging that implies more than the product is. Credibility should come from accurate information and testing.
- Over-ordering. Size first runs to the clinic’s realistic sell-through within shelf life.
- Letting notifications lapse. Notifications expire after two years without renewal.
- Limitation. This guide covers Malaysia; exporting a clinic range means checking each destination’s rules.
FAQ
Can a doctor sell their own skincare brand in their clinic?
Yes. Once each product is notified to NPRA by a Malaysian company acting as the notification holder, the range can be sold in the clinic, through pharmacies and online, as long as claims stay within cosmetic scope.
Do clinic skincare products need NPRA approval?
They need NPRA notification, not product approval. The notification holder files each product and variant in QUEST, pays RM50 per product and receives a notification note before manufacture or import.
What is the minimum order for a clinic skincare line?
Selected professional or ready-product options can begin from 12 units for a clinic trial. Eligible cosmetic and personal-care formats can pilot from 50 units under Ready2Brand, at about RM3,000, in 1–2 weeks. Adapted and custom formulas are quoted per format, packaging and testing.
Is “cosmeceutical” a legal category in Malaysia?
No. NPRA regulates these products as cosmetics. Claims that are medicinal in nature, or ingredients on the Poisons List, move a product out of the cosmetic route.
Can a clinic brand include post-procedure products?
Yes, as soothing, barrier-support cosmetics. Products claiming to heal wounds or manage scars may be medical devices and follow MDA rules instead.
Sources & references
- NPRA — Guidelines for Control of Cosmetic Products, 2.0 Cosmetic Notification — CNH responsibilities, QUEST submission, RM50 fee, two-year validity, notification note
- NPRA — 3.0 Regulatory Requirements for Cosmetics — claims must be justified and not medicinal; Poisons List and Annex II prohibitions; advertising guideline; GMP
- NPRA — Glossary for Cosmetic Guideline — definition of the cosmetic notification holder and of a cosmetic product
- NPRA — Cosmetic products main page — guidelines, annexes and directives
- Medical Device Authority (MDA) — regulator for products classified as medical devices
Update history: October 2026 — first published.
Planning a skincare line for your clinic? Start with our clinical skincare manufacturing pathway or share your concern, products and quantities for a route and claims review.
